Menu Back toSession-8-Final-Panel-Discussion-and-Key-Takeaways-Where-are-we-Heading-in-Terms-of-Transparency

Global Clinical Trials Transparency Conference


Session 8: Where are we Heading? The US and EU Industry associations’ perspective

Session Chair(s)

Merete  Joergensen, MBA, MSc

Merete Joergensen, MBA, MSc

  • Senior Trial Disclosure Director, Clinical Reporting Anchor & Disclosure
  • Novo Nordisk A/S, Denmark
Where are we Heading? The US and EU Industry associations’ perspective

Speaker(s)

Olivia  Shopshear, MS

Olivia Shopshear, MS

  • Senior Director, Science and Regulatory Advocacy
  • Pharmaceutical Research and Manufacturers of America (PhRMA), United States
Sini  Eskola, MPharm, MSc

Sini Eskola, MPharm, MSc

  • Director Regulatory Affairs
  • European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium